Zenotech Laboratories informs about outcome of board meeting

23 Jan 2021 Evaluate

Zenotech Laboratories has informed that pursuant to the provisions of Regulations 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the Company, at its meeting held on today, January 23, 2021 has considered and approved the Unaudited Financial Results along with Limited Review Report issued by the Statutory Auditors of the Company for the quarter and nine months ended December 31, 2020. A copy of the same is enclosed as Annexure I. The Board of Directors of the Company at their meeting held today has appointed Devendra Chandrakant S. Kenkre as the Chief Executive Officer of the Company with effective from today, January 23, 2021. The profile of Devendra Chandrakant S. Kenkre as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is enclosed as Annexure II. The meeting of the Board of Directors commenced on January 23, 2021 at 11:30 AM and concluded at 2:30 PM.

The above information is a part of company’s filings submitted to BSE.

Zenotech Laboratorie Share Price

76.22 0.02 (0.03%)
22-Nov-2024 15:44 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1215.35
Cipla 1486.25
Lupin 2072.60
Zydus Lifesciences 947.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.